AstraZeneca plc vs Dell Technologies Inc — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while Dell Technologies Inc trades at $451.8 (market cap $284.93B). The key difference: AstraZeneca plc and Dell Technologies Inc are close in size by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | DELL | |
|---|---|---|
Market Cap | $248.14B | $284.93B |
Sector | Health | Technology |
52-Week High | $209.48 | $467.27 |
52-Week Low | $147.06 | $111.10 |
Enterprise Value | $275.41B | $304.51B |
Dividend Yield | 2.01% | 0.57% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →